50 million doses of Covaxin set to expire early 2023 due to poor off take

Due to lack of product demand, production stoppage of Covaxin- a two dose jab, was initiated by Bharat Biotech earlier this year, though the vaccine maker has established manufacturing to reach an annualised capacity of 1 billion doses at the end of 2021.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/H0gDE9F
via IFTTT